Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study

医学 鼻咽癌 内科学 放射治疗 子群分析 临床终点 化疗 胃肠病学 多元分析 肿瘤科 置信区间 随机对照试验
作者
Fujuan Zeng,Tianzhu Lu,Fei Xie,Lizhi Chen,Lin Zhang,Yong Su,Zhongren Yu,Yun Xiao,Fan Ao,Guoqing Li,Zhiping Chen,Xiaochang Gong,Jingao Li
出处
期刊:Translational Oncology [Elsevier BV]
卷期号:14 (11): 101187-101187 被引量:27
标识
DOI:10.1016/j.tranon.2021.101187
摘要

BACKGROUND: To evaluate the value of locoregional radiotherapy (LRRT) in de novo metastatic nasopharyngeal carcinoma (dmNPC) and identify predictive factors for additional LRRT after palliative chemotherapy (PCT). METHODS: Overall survival (OS) was the primary endpoint. Patients who underwent PCT and LRRT were categorized as the PCT+LRRT group; patients who only received palliative chemotherapy were categorized as the PCT group. Oligometastatic diseases (OMD) was defined as ≤5 metastatic lesions and ≤2 metastatic organs. RESULTS: A total of 168 patients were included for this study. The median OS of patients in the PCT+LRRT group was significantly higher than those in the PCT group (57 months vs. 22 months, P<0.001). Multivariate analyses (MVA) showed that LRRT (HR=0.533, 95% CI: 0.319-0.889, P = 0.016) and OMD (HR=0.548, 95% CI: 0.331-0.907, P = 0.019) were independent prognostic factors for dmNPC. Furthermore, Kaplan-Meier analyses showed that the 3-year OS of patients who received LRRT was significantly better than those who did not receive LRRT in the OMD subgroup (66.3% vs. 25.2%, P<0.001). While, the 3-year OS of patients who received LRRT and without LRRT was no different in the polymetastatic disease (PMD) subgroup (38.9% vs.11.5%, P = 0.115). MVA showed that LRRT was a favorable prognosticator in the OMD subgroup (HR=0.308, 95% CI: 0.159-0.598; P<0.001), and not a favorable prognosticator in the PMD subgroup (HR=0.510, 95% CI: 0.256-1.014, P = 0.055). CONCLUSIONS: LRRT has the potential to prolong OS in NPC patients with de novo OMD. These results suggest that OMD is a potential indicator for filtering beneficiaries from LRRT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
Julie完成签到,获得积分10
刚刚
刚刚
刚刚
zhuang完成签到,获得积分10
1秒前
1秒前
CAOHOU的应助被科研通管家采纳,获得10
1秒前
天天快乐的应助被科研通管家采纳,获得10
1秒前
思源的应助被科研通管家采纳,获得10
2秒前
科研全白的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
不想起名字l完成签到,获得积分20
2秒前
入司的应助被科研通管家采纳,获得10
2秒前
2秒前
风吹麦浪的应助被科研通管家采纳,获得10
2秒前
2秒前
生动惜寒完成签到 ,获得积分10
2秒前
霸天狂龙完成签到,获得积分20
2秒前
2秒前
3秒前
Jasper的应助被科研通管家采纳,获得10
3秒前
小二郎的应助被科研通管家采纳,获得10
3秒前
英姑的应助被科研通管家采纳,获得10
3秒前
yiiyiiinine发布了新的文献求助10
3秒前
所所的应助被科研通管家采纳,获得10
3秒前
3秒前
3秒前
欣欣大王发布了新的文献求助10
3秒前
3秒前
3秒前
脑洞疼的应助被科研通管家采纳,获得30
3秒前
Owen的应助被科研通管家采纳,获得10
4秒前
亮仔完成签到,获得积分10
4秒前
打打的应助被科研通管家采纳,获得10
4秒前
Akim的应助被科研通管家采纳,获得10
4秒前
无极微光的应助被科研通管家采纳,获得20
4秒前
4秒前
无极微光的应助被科研通管家采纳,获得20
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192078
求助须知:如何正确求助?哪些是违规求助? 9578698
关于积分的说明 21861559
捐赠科研通 7791583
什么是DOI,文献DOI怎么找? 3436814
关于科研通互助平台的介绍 2560538
邀请新用户注册赠送积分活动 2483582